|Articles|March 1, 2012
- Pharmaceutical Executive-03-01-2012
- Volume 0
- Issue 0
Pharmaceutical Executive Digital Edition - March 2012
Leading in Emerging Markets
Advertisement
Articles in this issue
over 14 years ago
Novartis: LEADing in Emerging Marketsover 14 years ago
How Can We Fix the FDA?over 14 years ago
The Italian's Jobover 14 years ago
Off the Hook? Pharm Exec's Annual Press Auditover 14 years ago
The Maestrosover 14 years ago
The (Life) Science of Digital Connectionsover 14 years ago
Judging a Pill by its Coverover 14 years ago
When Talk is Not So CheapAdvertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on PharmExec
1
FDA Approves Lisraya for Adults with Dermatomyositis, Bixlenvo for Virologically Suppressed Adults with HIV, Mounjaro to Reduce MACE in Adults with Type 2 Diabetes
2
Trump Administration Preparing New Round of Medicaid Drug-Pricing Deals: Report
3
Pharmaceutical Executive Daily: DualityBio and Teva Strike Major Biopharma Deals
4
M&A Roundup: DualityBio & Genentech Enter Partnership to Develop Next Generation ADC’s, Teva Bids to Acquire Igalmi from BioXcel
5